Skip to content

Stryker SYK Total Equity

Discontinued — last reported Q4 '18

Total Equity at other companies

Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
Intuitive Surgical logo
Intuitive SurgicalISRG
$17.47B+2.2%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$12.67B+2.2%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
STERIS logo
STERISSTE
$7.18B+8.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$6.0B+2.6%
Gross profit$3.8B+1.8%
Operating income$936.0M+11.8%
Net income$745.0M+13.9%
EPS (diluted)$1.93+14.2%

Balance sheet

See full
Cash & equivalents$2.9B+24.1%
Total debt$14.4B-15.1%
Total assets$46.3B+0.6%

Cash flow

See full
Operating cash flow$581.0M+132%
CapEx$166.0M+35.0%
Free cash flow$415.0M+227%

Valuation

See full
Market cap$115.45B-11.4%
Enterprise value$126.95B-12.4%
P/E34.6×-11.0×
P/S4.6×-1.0×

Profitability

See full
Gross margin63.8%-0.1pp
Operating margin19.7%+4.4pp
Net margin13.2%+0.9pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.1×+0.5×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Stryker’s 10-K, filed February 7, 2019, on SEC EDGAR. View the filing →